Brief: DexTech: Positive Follow-Up Results In Phase IIb Study For OsteoDex

Dextech Medical AB

12/06/2020 11:02

June 12 (Reuters) - Dextech Medical AB  DEXTECH.TE :
    * DEXTECH'S PHASE IIB STUDY FOR OSTEODEX ENDS WITH POSITIVE
FOLLOW-UP RESULTS
    * PRIMARY ENDPOINTS OF STUDY CONCERNING MARKERS OF BONE
METABOLISM
HAVE BEEN WELL ACHIEVED
    * RESULTS OF STUDY ARE VERY POSITIVE AND SHOW THAT OSTEODEX
EFFECTIVELY SLOWS DOWN TUMOUR DISEASE
    * TREATMENT WAS VERY WELL TOLERATED (FEW AND MILD SIDE
EFFECTS)
AND GOOD DISEASE-SLOWING EFFECT WAS ALSO SEEN IN LOWEST DOSES
    * COMPANY'S INTENTION IS TO SIGN A LICENSE AGREEMENT BEFORE
END OF
CURRENT YEAR

Source text for Eikon:  ID:nWkr3yqnx0 
Further company coverage:  DEXTECH.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))